Slc:Wistar male rats treated with human natural tumor necrosis factor &alpha; (hn TNF-&alpha;, 3 X 105 Japan reference units/kg intravenously) for 3 months showed histologic vacuolation of basophils in the anterior pituitary, hyperplasia of the thyroidal follicular epithelium, and hyperplasia of the testicular interstitial cells. The vacuolated basophils were immunohistochemically shown to be thyrotrophs. In addition, there were decreases in plasma levels of triiodothyronine (T3), thyroxin (T4), and testosterone, and an increase in thyroid-stimulating hormone (TSH). The number of lymphocytes in the marginal zones of lymphoid follicles in spleen and lymph nodes and B-lymphocytes in the peripheral blood decreased. Hyperplasia of hematopoietic cells in the bone marrow and decreases in both leukocytes and erythrocytes in the peripheral blood were prominent. Hyperplasia of bile ductular epithelial cells with periportal mononuclear cell infiltration in the liver and increased cellularity in alveolar walls in the lung were also characteristic. In in vitro studies, hn TNF-&alpha; inhibited both proliferation and peroxidase activity of thyroid follicular epithelial cells. These findings demonstrate that hn TNF-&alpha; may induce histologic vacuolation of thyrotrophs by causing a decrease in plasma levels of T 3 and T 4 ; hyperplasia of the thyroid follicular epithelium, which may be attributed to the increased plasma level of TSH; hyperplasia of testicular interstitial cells, by lowering the plasma level of testosterone; hyperplasia of bile ductular epithelial cells; hyperplasia of hematopoietic cells in bone marrow; and the increase in cellularity in pulmonary alveolar walls. In addition, hn TNF-&alpha; may suppress the differentiation of B-lymphocytes.
INTRODUCTION
Human natural tumor necrosis factor a (hn TNF-a) has diverse biological effects on numerous endocrine cell types in vitro. TNF-a stimulates the production of growth hormone (12, 34) , luteinizing hormone (LH) (30) , and thyroid-stimulating hormone (TSH) (12) by the pituitary gland; suppresses thyroid hormone production by the thyroid follicular cells (16) ; and reduces testosterone secretion by interstitial cells of the testis (4) . In addition, TNFa affects the immune system by activating neutrophils (2, 6) and inducing proliferation and differentiation of both B-and T-lymphocytes (10, 19, 24, 25) and hematopoietic cells (14) . Administration of human recombinant TNF-a to rats caused hemorrhage, necrosis, and fibrosis in the thyroid gland, atrophy of seminiferous tubules in the testes, and transient neutrophilia and lymphopenia (27, 33) . Moreover, additional systemic effects of TNF-a have been described in the liver (8, 17, 32) , lungs (5, 18, 20, 26) , kidneys (3, 7) , and intestine (26) , but there have been few subchronic toxicity studies on hn TNF-a.
The purpose of this study was to determine the systemic toxic effects of a 3-month intravenous administration of hn TNF-a on rats. Additional in vitro studies were conducted to clarify the mechanisms of action of hn TNF-a that produced the morphologic changes observed.
MATERIALS AND METHODS
Animals. Slc:Wistar male rats (SLC, Shizuoka, Japan), 6 wk old, were individually housed in a room controlled at 23 ± 2°C and 55 w!-15% relative humidity with a 12hour-light/12-hour-dark cycle and were given a solid diet (gamma-irradiated CRF-1, Oriental Yeast, Tokyo, Japan) and water ad libitum during the experimental period. Test Substance. Phosphate-buffered saline (PBS) containing either hn TNF-&OElig; (4.06 X 105 - 4 .07 X 105 Japan reference units [JRU]/ml, Mochida Pharmaceutical, Tokyo, Japan) or human serum albumin (vehicle control) was used in this study.
The number of JRU for hn TNF-a was determined as follows: hn TNF-a sample was measured by a biological L-cell assay based on the cytotoxic activity of human recombinant TNF-a (lot J-PS5K01, 11,000 JRU/ml) as a reference standard against target cells (L-M cells, American Type Culture Collection) to obtain that dilution rate yielding 50% cell survival compared with the 100% cell survival of the vehicle control (31) . The number of JRU of hn TNF-a was obtained by multiplying the units of the reference solution giving 50% cell survival rate by the reciprocal of the dilution of hn TNF-a giving the 50% cell survival.
Toxicology Study. At 8 wk of age, the animals were divided into 2 groups of 5 rats each. They were treated intravenously with either hn TNF-&OElig; at 3 X 105 JRU per 2 ml/kg per day or with vehicle at 2 ml/kg per day for 90 days. The dose level of TNF-a used in this study was equivalent to the maximum-tolerated dose in a 90-day toxicity study in rats (data not shown). On the day after the final dose of hn TNF-a, heparinized blood samples were collected from the abdominal aorta under anesthesia with sodium pentobarbital (50 mg/kg intraperitoneally), and a portion of each sample was used for analysis of hematologic parameters and lymphocytic subpopulations by flow cytometry. The remaining part of each sample was centrifuged at 2,000 X g for 15 min at 4°C to isolate plasma, which was then used for hormone assays. TSH was measured by an immunoradiometric assay (21) . Triiodothyronine (T3) and thyroxin (T4) were determined by radioimmunoassay (29) using DELFIA Total T3 kit and T4 kit (Pharmacia Diagnostics, Uppsala, Sweden), respectively. Also, testosterone was measured by radioimmunoassay (11) with a DELFIA Total testosterone kit (Pharmacia Diagnostics). After blood sampling, the animals were sacrificed by exsanguination under sodium pentobarbital (50 mg/kg intraperitoneally) anesthesia. Immediately after death, the cerebrum and cerebellum, pituitary gland, thyroid glands, adrenal glands, heart, lungs, liver, submandibular salivary glands, thymus, spleen, testes, epididymides, and prostate gland were removed and weighed. In addition, spinal cord, eye, optic nerve, Harderian glands, bronchus, esophagus, stomach, small and large intestines, pancreas, urinary bladder, femur with bone marrow, sternum with bone marrow, submandibular lymph nodes, mesenteric lymph nodes, skin, mammary glands, vastus lateralis muscles, and sciatic nerves were removed. All these organs and tissues were fixed in 10% phosphate-buffered formaldehyde solution, routinely processed and embedded in paraffin, and sectioned at a 3-pLm thickness. These sections were stained with hematoxylin-eosin or with Berlin blue for light microscopy or were processed for immunohistochemistry. Immunohistochemistry. The sections were deparaffinized with xylene, hydrated in ethanol gradients, and immersed in 3% H202 to inhibit endogenous peroxidase activity. LH and TSH in the pituitary gland and testosterone in the testes were immunohistochemically stained with goat anti-rat LH antibody (UCB-Bioproducts, Cambridge, UK), goat anti-rat TSH antibody (UCB-Bioproducts), and goat anti-rat testosterone antibody (UCB-Bioproducts), respectively. B-and T-lymphocytes in the spleen were immunohistochemically stained with mouse monoclonal antibody against rat B-lymphocytes (MCA340, Serotec, Oxford, England) and mouse monoclonal antibody against rat T-lymphocytes (MCA52, Serotec). Biotinylated rabbit anti-goat (E0466, Dako, Glostrup, Denmark) or goat antimouse (E0432, Dako) antibodies were used as secondary antibodies. The streptavidin-biotin method (LSAB2 universal kit, Dako) was used for amplification, and diaminobenzidine was the final indicator.
Flow Cytometry. For analysis of the subpopulations of B-and T-lymphocytes, 100 lil of heparinized blood from each animal was first reacted with mouse anti-rat B-lymphocyte antibody (MCA340) or with mouse anti-rat Tlymphocyte antibody (MCA52) at 4°C for 30 min. Cells were washed with 0.01 M PBS and then stained with fluorescein isothiocyanate (FITC)-conjugated goat antimouse IgG antibody (F0479, Dako). For separate detection of CD4-positive T-lymphocytes (CD4 lymphocytes) and CD8-positive T-lymphocytes (CD8 lymphocytes), additional 100-[LI samples were simultaneously reacted with both FITC-conjugated anti-rat CD4 antibody (Pharmingen, San Diego, CA) and phycoerythrin (PE)-conjugated anti-rat CD8 antibody (Pharmingen) at 4°C for 30 min. After termination of these reactions, each sample was hemolyzed with 0.83°7o ammonium chloride solution, washed with PBS twice, and analyzed with an EPICS ELITE (Coulter, Tokyo, Japan) flow cytometer (Excitation : 488 nm, Emission: 504-541 nm for FITC and 568-590 nm for PE, Detection: 525 + 15 nm for FITC and 575 + 15 nm for PE). Forward and side light scatterings were measured as an index of particle size, and emission of FITC or of PE fluorescence within the lymphocytic area was estimated. The number of each lymphocyte sub-TABLE IIL-Absolute and relative organ weights analyzed with Student's t-test; each value represents the mean ± standard deviation (n = 5).~o -Histologic characterization of pituitary and thyroid glands from control (A, C, D, and G) and hn TNF-a-treated (B, E, F, and H) rats. Pituitary gland from the control rat showing normal structures in the anterior lobe (A). Numerous vacuolated basophils (arrows) were observed in the anterior lobe from the hn TNF-a-treated rat (B). By immunohistochemistry for LH (C and E) and TSH (D and F), the vacuolated basophils were negative for LH (D) but positive for TSH (F). Thyroid glands from the control rat showing normal structures (G). The hn TNF-a-treated rats showed moderate hyperplasia of the follicular epithelium with an increase in the number of small follicles and desquamation of follicular epithelial cells into the follicular cavity (H). Bar = 50 jjbm. population was calculated based on the proportion of lymphocytes to total leukocytes. Experiments In Vitro. Effect of hn TNF-a on Rat Thyroid Follicular Cells. For isolation of thyroid follicular cells, 3 untreated Slc:Wistar male rats (7 wk old) were sacrificed by exsanguination under anesthesia with sodium pentobarbital (50 mg/kg intraperitoneally), and their thyroid glands were then removed, placed in a plastic dish, washed with sterilized PBS (pH 6.8), trimmed, minced with a surgical knife, washed with PBS, and transferred to a tube. Five milliliters of minimum essential medium (MEM) supplemented with 0.3% collagenase was added to the tube containing the thyroid fragments and incubated at 37°C for 60 min with shaking (100 times/min). The collagenase-treated tissue was then filtered through a cell strainer (FALCON, Becton Dickinson, Lincoln Park, NJ), and the filtrate was centrifuged at 700 X g for 10 min at 4°C. After decantation, the pellet was again incubated in MEM supplemented with 0.3% collagenase under the same conditions described herein.
After centrifugation (700 X g, 10 min, 4°C), the pellet was incubated in MEM supplemented with 0.25% trypsin at 37°C for 20 min with stirring, and then centrifuged at 700 X g for 10 min at 4°C. After decantation, the pellet was washed with culture medium (AIV-M medium, Gibco), and the number of cells was adjusted to 1 X 10'/ml by counting with a hemocytometer (Burker-Turk, Erma Inc, Tokyo, Japan) under a microscope. Then, 1 X 105
-Histologic characterization of testes from control (A and C)
and hn TNF-a-treated (B and D) rats. Normal structures were observed in the control rat testis (A). Severe degeneration of germinal epithelium with hyperplasia of interstitial cells was noticeable in the hn TNF-atreated rat (B). By immunohistochemistry for testosterone, the interstitial cells from the control rat (C) were positive for testosterone, but the proliferated interstitial cells from the hn TNF-a-treated rat (D) showed markedly reduced staining. Bar = 50 J.1.m. cells were seeded into each of several plastic dishes (35mm diameter, PRIMARIA, FALCON) and incubated in the absence or presence of rat TSH ( 1 ~,U/ml, UCB-Bioproducts) at 37°C under an atmosphere of 5% CO,/95% air with 10 [LI of hn TNF-a solution (10, 30, 100, 300, or 1,000 JRU/ml as the final concentration). Incubation was carried out for 21 days with a medium change twice a week, under an atmosphere of 5% CO,,/95% air. After cultivation, the number of viable cells was counted microscopically, and for assessment of enzyme activities, the cells were then treated with PBS containing 0.25% trypsin at 37°C for 5 min and subsequently homogenized in PBS with a sonicator (B. B. Brown, Bonn, Germany). E, ffect of hn TNF-a on Peroxidase Activity and on Thyroxin 5'-Deiodinase Activity in the Rat Thyroid. For preparation of thyroid gland homogenates, 3 untreated Slc: Wistar rats (7-wk-old males) were sacrificed by exsanguination in the same manner as described herein, and their thyroid glands were removed. The glands were washed with 0.1 M PBS (pH 6.8) supplemented with 0.25 M sucrose and then homogenized in the same solution with a Wahring blender (Nihonseiki, Tokyo, Japan).
For determination of thyroid peroxidase activity, the homogenate was used as a source of thyroid peroxidase.
To each tube, 0.3 ml of 33 IThB1 guaiacol sodium, 0.3 ml of 0.27 mNt hydrogen peroxide, and 2.3 ml of 0.1 M PBS (pH 7.4) were added and mixed. Then, 0.1 ml of the thyroid homogenate and 0.1 mI of hn TNF-a solution (10, 30 , 100, 300, or 1,000 JRU/ml as the final concentration) were mixed and incubated at 37°C for 10 min. After incubation, the absorbance of the mixture at 470 nm was determined with a spectrophotometer. Enzyme activity was defined as the amount of oxidized guaiacol produced per 1 min.
For determination of thyroxin 5'-deiodinase activity, microsomes were harvested by centrifuging the homogenates at 700 X g for 10 min at 4°C, and then the supematants were separated and again centrifuged at 7,000 X g for 10 min at 4°C. The supernatants were finally centrifuged at 10,500 X g for 10 min at 4°C. After decantation, the pellets were suspended in 0.1 M PBS (pH 6.8) supplemented with 0.25 M sucrose solution and were used as a source of thyroxin 5'-deiodinase derived from the thyroid gland. The protein concentration in the microsomes was determined by use of a protein assay kit (Bio-Rad Laboratories, Richmond, CA). Thyroxin 5'deiodinase activity was determined by mixing 0.4 ml of the microsome suspension with 0.4 ml of substrate solution (0.1 mg/ml L-thyroxin [Sigma Chemical Co., St. Louis, MO], 10 mM 2-mercaptoethanol [Wako Pure Chemical Inc., Osaka, Japan], and 25 mM PBS [pH 6 .0]) in a tube and then adding 0.1 ml of hn TNF-a solution (10, 30, 100, 300, or 1,000 JRU/ml as the final concentration) and incubating the mixture at 37°C for 10 min with stirring. After incubation, 0.1 ml of 1 N hydrochloric acid solution and 2 ml of 100% ethanol were sequentially added. The mixture was centrifuged at 7,000 X g for 10 min at 4°C, and the supernatant was separated. The conversion of T4 to T3 in the supernatant was determined by use of a DELFIA system (Pharmacia Biotech, Uppasala, Sweden). The enzyme activity was presented as the amount of T3 produced per 1 min. Statistical Analysis. Values were expressed as the means-SD. Data were analyzed by Student's t-test to assess significant differences between the control and hn TNF-a groups at p < 0.05.
RESULTS

Toxicology Study
After the first and second doses, a decrease in general motor activity, mucoid feces, and increased lacrimation were observed in almost all the animals treated with hn TNF-a. In addition, some animals showed bloody feces. However, these clinical signs disappeared after the third dose. At the end of experimental period, significant differences evaluated using Student's t-test (p < 0.01) were observed in body weight and total food intake between control and hn TNF-a groups (weight: 323 ± 8 g and 278 -~ 6 g, respectively; food intake: 1512 -!-133 g and 1242 ± 82 g, respectively).
In the hn TNF-a-treated rats, total erythrocytes, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular concentration, and neutrophils were decreased significantly. Leukocytes and total lymphocytes in the treated animals tended to decrease. Conversely, reticulocyte counts had increased significantly. Additionally, the number of B-lymphocytes was significantly decreased but that of T-lymphocytes and its subpopulations showed no significant changes (Table   I ).
The hn TNF-a-treated rats showed significant decreases in T3, T4, and testosterone levels and tended to have an increased plasma level of TSH (Table II) .
Absolute and relative weights of the thyroid glands, lungs, and spleen increased significantly in the hn TNFa-treated rats. Changes in other relative organ weights were a result of a decrease in final body weight (Table   III ).
In the pituitary gland of the hn TNF-a-treated rats (Fig. 1B) , severe vacuolar degeneration of basophils was histologically present in the anterior lobe. Vacuolated basophils were positive for TSH ( Fig. IF) but negative for LH (Fig. 1E ). In the thyroid gland, moderate hyperplasia of the follicular epithelium with an increased number of small follicles and desquamation of epithelial cells were observed (Fig. 1 H) .
In the testis of the hn TNF-a&horbar;treated rats (Fig. 2B ), severe degeneration of germinal epithelium with hyperplasia of interstitial cells was present. The interstitial cells that had proliferated (Fig. 2D ) were weakly positive for testosterone compared with the normal interstitial cells (Fig. 2C ).
In the spleen of the hn TNF-a-treated rats (Fig. 3B ), the red pulp was slightly expanded, and the degree of hemosiderin deposition was less (Fig. 3D ) than that in the control rats (Fig. 3A, B ). In the splenic lymphoid follicles from the hn TNF-a-treated rat (Fig. 4B ), the number of lymphocytes in the marginal zone was noticeably decreased. The marginal zones of the spleen from the control rats contained numerous lymphocytes (Fig.   4A ) that were immunohistochemically identified as Bcells reactive with MCA340 (Fig. 4C ). Marginal zones from the hn TNF-a-treated rats had comparatively few B-lymphocytes with MCA340 positivity (Fig. 4D ). There was no apparent difference in the immunohistochemistry of T-lymphocytes in the periarterial lymphatic sheath of the spleen between the control (Fig. 4E) and hn TNF-atreated rats (Fig. 4F) .
The thymic cortex from the hn TNF-a-treated rats showed moderate atrophy (Fig. 5B ), and severe hyperplasia of hematopoietic cells, including both erythropoietic and myelopoietic cells, was observed in the femoral bone marrow (Fig. 5D ). Bile ductular hyperplasia and mononuclear cell infiltration into Glisson's sheath in the liver were observed in moderate degree in the hn TNFa-treated rats (Fig. 5F ). In addition, the lungs from the treated rats showed a slight increase in cellularity in the FIG. 4.-Histologic characterization of spleen from control (A, C, and E) and hn TNF-a-treated (B, D, and F) rats. The number of lymphocytes in the marginal zone of the spleen from the hn TNF-a-treated rat (B) was remarkably decreased compared with that of the control rat (A). By immunohistochemistry, lymphocytes in the marginal zone of the spleen from the control rat (C) were positive for MCA340 (antibody to rat Blymphocytes). A decrease in the number of MCA340-positive lymphocytes was observed in the marginal zone from the hn TNF-a-treated rat (D). Lymphocytes in the splenic periarterial lymphoid sheath from the control rat reacted positively with MCA52 (antibody to rat T-lymphocytes) (E). Those in sections from the hn TNF-a-treated rat gave staining similar to those from the control rat (F). F = follicle; M = marginal zone; bar = 50 jjbm. alveolar walls, which was attributed to infiltration of inflammatory cells into the alveolar walls and proliferation of type II alveolar epithelial cells (Fig. 5H) .
Animals in the hn TNF-&OElig;-treated group displayed these lesions, but none of the control animals showed them.
Experiments In Vitro
The hn TNF-a did not have a direct effect on either thyroid peroxidase activity or thyroxin 5'-deiodinase activity in 10-min cultures or in homogenates from the liver or pituitary gland (data not shown). In cultures of thyroid follicular cells, the number of thyroid cells was reduced in a concentration-dependent fashion by treatment with 100-1,000 JRU/ml of TNF-&OElig; (Fig. 6 ). Although TSH increased the thyroid cell number, hn TNF-&OElig; had an in-hibitory effect on cell number both in the presence and in the absence of TSH (Fig. 6 ). Finally, both thyroxin 5'deiodinase and peroxidase activities of the thyroid cells were decreased when hn TNF-a was added to the culture medium, although only at high concentrations for 5'deiodinase activity (Fig. 7) .
DISCUSSION
Long-term (3-month) administration of hn TNF-cx to rats induced multiple endocrinologic and immune system abnormalities. The decreased plasma thyroid hormone levels, increased thyroid gland weights, thyroid follicular cell hyperplasia, and vacuolated thyrotrophs with TSH immunoreactivity in the pituitary all suggest that perturbation of the thyroid-pituitary axis had occurred. The development of vacuolated thyrotrophs is well known in FIG. 5.-Histologic characterization of thymus (A and B), bone marrow (C and D), liver (E and F), and lung (G and H) from control and hn TNF-a-treated rats. Cortex was moderately atrophied in the thymus from the hn TNF-a-treated rat (B) compared with that of the control rat (A). Femoral bone marrow from the control rat showed the normal structure (C); on the contrary, hyperplasia of hematopoietic cells, including both erythropoietic and myelopoietic cells, was noticeable in the femoral bone marrow from the hn TNF-a-treated rat (D). Normal structures were observed in the control rat liver (E). The liver from the hn TNF-a-treated rat (F) showed moderate hyperplasia of bile ductules (arrowheads) and mononuclear cell infiltration in Glisson's sheath. Normal structures were observed in the control rat lung (G). The lung from the hn TNF-a-treated rat (H) showed a slight increase in the cellularity of the alveolar walls. Inflammatory cell (arrows) infiltration and signs of proliferation of type II alveolar epithelial cells (arrowheads) were marked. Bar = 50 u.m. thyroidectomized animals and in animals treated with antithyroid drugs (15) . Inhibition of thyroid peroxidase in vivo was suggested by decreased peroxidase activity in vitro at lower concentrations than the plasma level achieved at an intravenous dose of 3 X 105 JRU/kg of hn TNF--« in vivo. In addition, hn TNF-a apparently in-hibited the proliferation of the thyroid cells in vitro. These findings suggest a possible direct inhibitory effect of hn TNF-a on the thyroid gland. However, the inability of hn TNF-a to inhibit thyroid hyperplasia in vivo may have been due to decreases in plasma T3 and T4 levels and a resultant increase in the plasma level of TSH by FIG. 6.-Effect of hn TNF-a on growth of rat thyroid cells cultured for 21 days. Each column represents the mean ± SD (n = 3). Data were analyzed by analysis of variance. A significant difference from the control: ** p < 0.01. feedback from the thyroid-pituitary axis at a dose of 3 X 105 JRU/kg. Decreased plasma testosterone level, interstitial cell hyperplasia, and decreased testosterone immunoreactivity in the interstitial cells suggest perturbation of the testispituitary axis. But there was no change in LH immunoreactivity in the gonadotrophs of the pituitary at this time. It is well known that hyperplasia and/or neoplasia of interstitial cells spontaneously occurs in aged rats or can be induced by various drugs in rats (9) . However, there is no report of such changes in mice. The 90-day intravenous administration of 3 X 105 JRU/kg of hn TNF-a did not induce interstitial cell hyperplasia or tumor development in mice (C. Kakinuma et al, unpublished data). Thus, there is an apparent species difference in development of interstitial cell hyperplasia induced by hn TNF-a between rats and mice. The development of hn TNF-&OElig;-induced interstitial cell hyperplasia may be explained by the following hypothesis: hn TNF-&OElig; decreases the production of testosterone by interstitial cells, resulting in an increase in plasma level of LH by feedback from the hypothalamo-pituitary-gonadal axis. Then, the downregulation of LH receptors and the upregulation of LH releasing hormone receptors on rat interstitial cells are induced, and the latter may play an important role in the development of the interstitial cell hyperplasia in rats (9) . This hypothesis is supported by the observation that hn TNF-a did not induce the interstitial cell hyperplasia in mice, which are known to lack the LH releasing hormone receptors on their cells (9) . Additionally, severe degeneration of germinal epithelium is considered to be a secondary event induced by lowering of the plasma -Effect of hn TNF-a on peroxidase and 5'-deiodinase activities in rat thyroid cells cultured for 21 days. Each column represents the mean ± SD (n = 3). Data were analyzed by analysis of variance. A significant difference from the control: ** p < 0.01. inhibitory effects of hn TNF-cx on differentiation or proliferation of B-lymphocytes. On the other hand, the cortical atrophy noted in the thymus has been attributed to stress-associated involution (22) .
Anemia was a characteristic of the hn TNF-a-treated animals. It has been reported that anemia induced by TNF-a is hypoferric anemia associated with impaired iron release from the reticuloendothelial system (1, 13) .
Because the anemia in this study was hypochromic microcytic anemia with decreased plasma levels of iron (control group: 227 ± 14 ~.g/dl, hn TNF-a-treated group: 162 ± 8 pLg/dl) and an increased number of peripheral reticulocytes, it appears to have been induced by the same mechanism as described previously (1, 13) . Furthermore, we noticed the occurrence of neutropenia in the hn TNFa-treated rats. This change is supported by the observation of Ulich et al (28) , who showed that TNF-a induced neutropenia in rats by causing neutrophils to leave the circulating pool rather than by decreasing neutrophil release from the bone marrow. However, its mechanism remains unclear.
Hyperplasia of intrahepatic bile ductuli in rats treated with hn TNF-a may have resulted from the proliferative effect of hn TNF-a on bile ductular epithelial cells through a TNF-a receptor-mediated process (32) .
We observed an increased cellularity in pulmonary alveolar walls and an increase in lung weight in rats treated with hn TNF-a. TNF-a was reported to play a role in the development of pulmonary toxicity (20) or to mediate lung inflammation (23) . Sueoka et al (26) mentioned that lymphocytes and macrophages infiltrated into alveolar septa in transgenic mice that overexpressed TNF-a. These facts taken together make it seem likely that the increased cellularity in the lungs may have been induced by infiltration of inflammatory cells and proliferation of type II alveolar cells mediated by the biological actions of TNF-&OElig;.
In conclusion, the present study suggests that longterm administration of hn TNF-a to rats induces morphologically observable proliferative changes, i.e., hyperplasia of thyroid follicular epithelium, testicular interstitial cells, and bile ductular epithelial cells. Also in the lung, at least type II alveolar epithelial cells proliferated and partly participated in the increased cellularity seen in the alveolar walls. In addition, the inhibitory effects of hn TNF-&OElig; on peripheral blood cells, i.e., erythrocytes, neutrophils, and B-lymphocytes, were evidenced. By determination of hormone concentrations and flow cytometrical analysis, the mechanisms were partly explained in terms of the hormone-network system and immune system.
